Viewing Study NCT06111235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-01-21 @ 7:10 AM
Study NCT ID: NCT06111235
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-09
First Post: 2023-10-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Sponsor: CG Oncology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Muscle Invasive Bladder Cancer View
None Urologic Cancer View
None Bladder Cancer View
None Urothelial Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urology View
None Bladder Cancer View
None Non Muscle Invasive Bladder Cancer View
None Intermediate Risk Non Muscle Invasive Bladder Cancer View
None Cretostimogene Grenadenorepvec View